GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 50.39 USD 0.34% Market Closed
Market Cap: 102.7B USD

Wall Street
Price Targets

GSK Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GSK stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSK is 49.58 USD with a low forecast of 39.07 USD and a high forecast of 71.99 USD.

Lowest
Price Target
39.07 USD
22% Downside
Average
Price Target
49.58 USD
2% Downside
Highest
Price Target
71.99 USD
43% Upside
GlaxoSmithKline PLC Competitors:
Price Targets
ZYDUSLIFE
Zydus Lifesciences Ltd
16% Upside
SANOFI
Sanofi India Ltd
22% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
35% Upside
234080
JW Life Science Corp
46% Upside
4578
Otsuka Holdings Co Ltd
9% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
39% Upside
13
HUTCHMED (China) Ltd
44% Upside
603998
Hunan Fangsheng Pharmaceutical Co Ltd
36% Upside

Revenue
Forecast

Revenue Estimate
GlaxoSmithKline PLC

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 1%. The projected CAGR for the next 4 years is 5%.

1%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
GlaxoSmithKline PLC

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 0%. The projected CAGR for the next 4 years is 12%.

0%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
GlaxoSmithKline PLC

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -5%. The projected CAGR for the next 4 years is 16%.

-5%
Past Growth
16%
Estimated Growth
Estimates Accuracy
55%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSK's stock price target?
Price Target
49.58 USD

According to Wall Street analysts, the average 1-year price target for GSK is 49.58 USD with a low forecast of 39.07 USD and a high forecast of 71.99 USD.

What is GlaxoSmithKline PLC's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 1%. The projected CAGR for the next 4 years is 5%.

What is GlaxoSmithKline PLC's Operating Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 0%. The projected CAGR for the next 4 years is 12%.

What is GlaxoSmithKline PLC's Net Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -5%. The projected CAGR for the next 4 years is 16%.

Back to Top